Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Affinia, Astellas, Bridgebio, Exelixis,Grifols,Johnson & Johnson, Neurocrine, Puretech, Rigel, RQ, Stallergenes, Zentalis.